Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Photoaffinity labeling of adenylyl cyclase.

Sievert MK, Pilli G, Liu Y, Sutkowski EM, Seamon KB, Ruoho AE.

Methods Enzymol. 2002;345:188-97. No abstract available.

PMID:
11665604
2.

Specifications for biotechnology-derived protein drugs.

Seamon KB.

Curr Opin Biotechnol. 1998 Jun;9(3):319-25. Review.

PMID:
9650276
3.

Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.

Sutkowski EM, Robbins JD, Tang WJ, Seamon KB.

Mol Pharmacol. 1996 Aug;50(2):299-305.

PMID:
8700137
4.

Forskolin carbamates: binding and activation studies with type I adenylyl cyclase.

Robbins JD, Boring DL, Tang WJ, Shank R, Seamon KB.

J Med Chem. 1996 Jul 5;39(14):2745-52.

PMID:
8709105
5.

Purification of bovine brain adenylyl cyclase with a novel derivative of forskolin: evidence for a high specific activity form of the enzyme.

Moos M Jr, Morris DI, Robbins J, Appel L, Seamon KB.

Prep Biochem Biotechnol. 1996 May;26(2):155-67.

PMID:
8784925
6.

Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.

Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB, Tew KD.

Mol Pharmacol. 1994 Nov;46(5):866-72.

PMID:
7969073
7.

Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.

Sutkowski EM, Tang WJ, Broome CW, Robbins JD, Seamon KB.

Biochemistry. 1994 Nov 1;33(43):12852-9.

PMID:
7947691
8.

Forskolin specifically inhibits the bacterial galactose-H+ transport protein, GalP.

Martin GE, Seamon KB, Brown FM, Shanahan MF, Roberts PE, Henderson PJ.

J Biol Chem. 1994 Oct 7;269(40):24870-7.

9.

Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.

Morris DI, Greenberger LM, Bruggemann EP, Cardarelli C, Gottesman MM, Pastan I, Seamon KB.

Mol Pharmacol. 1994 Aug;46(2):329-37.

PMID:
7915819
10.

Homologous sugar-transport proteins in microbes and man.

Henderson PJ, Roberts PE, Martin GE, Seamon KB, Walmsley AR, Rutherford NG, Varela MF, Griffith JK.

Biochem Soc Trans. 1993 Nov;21(4):1002-6. Review. No abstract available.

PMID:
8131886
11.

Evaluation of genetic stability.

Seamon KB.

Biologicals. 1993 Jun;21(2):153-4. No abstract available.

PMID:
8297597
12.
15.

Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.

Daly JW, Caceres J, Moni RW, Gusovsky F, Moos M Jr, Seamon KB, Milton K, Myers CW.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10960-3.

16.

Differential identification and localization of adenylyl cyclase and glucose transporter in brain using iodinated derivatives of forskolin.

Robbins JD, Appel NM, Laurenza A, Simpson IA, De Souza EB, Seamon KB.

Brain Res. 1992 May 22;581(1):148-52.

PMID:
1498664
18.

Genetic and biochemical factors affecting product consistency: introduction to the issues.

Seamon KB.

Dev Biol Stand. 1992;76:63-7. No abstract available.

PMID:
1478357
19.
20.

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.

Carrow EW, Vujcic LK, Glass WL, Seamon KB, Rastogi SC, Hendry RM, Boulos R, Nzila N, Quinnan GV Jr.

AIDS Res Hum Retroviruses. 1991 Oct;7(10):831-8.

PMID:
1720630
21.

Interaction of forskolin with the P-glycoprotein multidrug transporter.

Morris DI, Speicher LA, Ruoho AE, Tew KD, Seamon KB.

Biochemistry. 1991 Aug 27;30(34):8371-9.

PMID:
1679346
22.

Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter.

Morris DI, Robbins JD, Ruoho AE, Sutkowski EM, Seamon KB.

J Biol Chem. 1991 Jul 15;266(20):13377-84.

23.

Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism.

Lippincott-Schwartz J, Glickman J, Donaldson JG, Robbins J, Kreis TE, Seamon KB, Sheetz MP, Klausner RD.

J Cell Biol. 1991 Feb;112(4):567-77.

24.

High-affinity binding sites for [3H]forskolin.

Laurenza A, Seamon KB.

Methods Enzymol. 1991;195:52-65. No abstract available.

PMID:
2034120
25.

cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.

Harvath L, Robbins JD, Russell AA, Seamon KB.

J Immunol. 1991 Jan 1;146(1):224-32.

PMID:
1701793
26.

Localization of the forskolin photolabelling site within the monosaccharide transporter of human erythrocytes.

Wadzinski BE, Shanahan MF, Seamon KB, Ruoho AE.

Biochem J. 1990 Nov 15;272(1):151-8.

27.

Immunoprecipitation of adenylate cyclase with an antibody to a carboxyl-terminal peptide from Gs alpha.

Morris D, McHugh-Sutkowski E, Moos M Jr, Simonds WF, Spiegel AM, Seamon KB.

Biochemistry. 1990 Sep 25;29(38):9079-84.

PMID:
2125472
29.

Identification of cell surface receptors for the Act-2 cytokine.

Napolitano M, Seamon KB, Leonard WJ.

J Exp Med. 1990 Jul 1;172(1):285-9.

30.
31.

Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

Laurenza A, Sutkowski EM, Seamon KB.

Trends Pharmacol Sci. 1989 Nov;10(11):442-7. Review.

PMID:
2692256
32.

Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody.

Halpern JL, Smith LA, Seamon KB, Groover KA, Habig WH.

Infect Immun. 1989 Jan;57(1):18-22.

33.
34.

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6).

Tosato G, Seamon KB, Goldman ND, Sehgal PB, May LT, Washington GC, Jones KD, Pike SE.

Science. 1988 Jan 29;239(4839):502-4.

PMID:
2829354
35.

Binding of [3H]forskolin to solubilized preparations of adenylate cyclase.

Nelson CA, Seamon KB.

Life Sci. 1988;42(14):1375-83.

PMID:
3352459
36.

Stimulation of adenylate cyclase by water-soluble analogues of forskolin.

Laurenza A, Khandelwal Y, De Souza NJ, Rupp RH, Metzger H, Seamon KB.

Mol Pharmacol. 1987 Jul;32(1):133-9.

PMID:
3600614
38.

Forskolin: its biological and chemical properties.

Seamon KB, Daly JW.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1986;20:1-150. Review. No abstract available.

PMID:
3028083
39.
40.

Modulation of forskolin binding to rat brain membranes.

Seamon KB, Vaillancourt R, Daly JW.

J Cyclic Nucleotide Protein Phosphor Res. 1985;10(6):535-49.

PMID:
4086675
41.

High-affinity binding of forskolin to rat brain membranes.

Seamon KB, Daly JW.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985;19:125-35.

PMID:
3159185
42.

Binding of [3H]forskolin to rat brain membranes.

Seamon KB, Vaillancourt R, Edwards M, Daly JW.

Proc Natl Acad Sci U S A. 1984 Aug;81(16):5081-5.

43.

Interaction of forskolin with dually regulated adenylate cyclase.

Seamon KB, Wetzel B.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:91-9.

PMID:
6328948
44.

Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives.

Seamon KB, Daly JW, Metzger H, de Souza NJ, Reden J.

J Med Chem. 1983 Mar;26(3):436-9.

PMID:
6681845
46.

Calmodulin stimulation of adenylate cyclase in rat brain membranes does not require GTP.

Seamon KB, Daly JW.

Life Sci. 1982 Apr 26;30(17):1457-64.

PMID:
7087674
48.

Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

Seamon KB, Padgett W, Daly JW.

Proc Natl Acad Sci U S A. 1981 Jun;78(6):3363-7.

49.

Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Seamon KB, Daly JW.

J Cyclic Nucleotide Res. 1981;7(4):201-24. Review.

PMID:
6278005
50.

Octopus calmodulin. Structural comparison with bovine brain calmodulin.

Seamon KB, Moore BW.

J Biol Chem. 1980 Dec 25;255(24):11644-7.

Supplemental Content

Loading ...
Support Center